39 related articles for article (PubMed ID: 15194049)
1. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model.
Janát-Amsbury MM; Yockman JW; Lee M; Kern S; Furgeson DY; Bikram M; Kim SW
Mol Ther; 2004 Jun; 9(6):829-36. PubMed ID: 15194049
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J
Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417
[TBL] [Abstract][Full Text] [Related]
3. Intricacies for posttranslational tumor-targeted cytokine gene therapy.
Cutrera J; Dibra D; Satelli A; Xia X; Li S
Mediators Inflamm; 2013; 2013():378971. PubMed ID: 24369443
[TBL] [Abstract][Full Text] [Related]
4. High dose, dual-release polymeric films for extended surgical bed paclitaxel delivery.
Mahvi DA; Korunes-Miller J; Bordeianu C; Chu NQ; Geller AD; Sabatelle R; Berry S; Hung YP; Colson YL; Grinstaff MW; Raut CP
J Control Release; 2023 Nov; 363():682-691. PubMed ID: 37776906
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers.
Ahn HH; Carrington C; Hu Y; Liu HW; Ng C; Nam H; Park A; Stace C; West W; Mao HQ; Pomper MG; Ullman CG; Minn I
Sci Rep; 2021 May; 11(1):9733. PubMed ID: 33958660
[TBL] [Abstract][Full Text] [Related]
6. Local Interleukin-12 Treatment Enhances the Efficacy of Radiation Therapy by Overcoming Radiation-Induced Immune Suppression.
Yu CF; Chang CH; Wang CC; Hong JH; Chiang CS; Chen FH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576217
[TBL] [Abstract][Full Text] [Related]
7. Localized Interleukin-12 for Cancer Immunotherapy.
Nguyen KG; Vrabel MR; Mantooth SM; Hopkins JJ; Wagner ES; Gabaldon TA; Zaharoff DA
Front Immunol; 2020; 11():575597. PubMed ID: 33178203
[TBL] [Abstract][Full Text] [Related]
8. Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors.
Wang H; Najibi AJ; Sobral MC; Seo BR; Lee JY; Wu D; Li AW; Verbeke CS; Mooney DJ
Nat Commun; 2020 Nov; 11(1):5696. PubMed ID: 33173046
[TBL] [Abstract][Full Text] [Related]
9. Polymer-mediated gene therapy: Recent advances and merging of delivery techniques.
Salameh JW; Zhou L; Ward SM; Santa Chalarca CF; Emrick T; Figueiredo ML
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1598. PubMed ID: 31793237
[TBL] [Abstract][Full Text] [Related]
10. p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.
Lu P; Redd Bowman KE; Brown SM; Joklik-Mcleod M; Vander Mause ER; Nguyen HTN; Lim CS
Mol Pharm; 2019 Aug; 16(8):3386-3398. PubMed ID: 31241338
[TBL] [Abstract][Full Text] [Related]
11. Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs' Dosage Ratio Effect.
Pan J; Rostamizadeh K; Filipczak N; Torchilin VP
Molecules; 2019 Mar; 24(6):. PubMed ID: 30875934
[TBL] [Abstract][Full Text] [Related]
12. Double domain polyethylenimine-based nanoparticles for integrin receptor mediated delivery of plasmid DNA.
Sadeghpour H; Khalvati B; Entezar-Almahdi E; Savadi N; Hossaini Alhashemi S; Raoufi M; Dehshahri A
Sci Rep; 2018 May; 8(1):6842. PubMed ID: 29717202
[TBL] [Abstract][Full Text] [Related]
13. Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.
Darvishi B; Farahmand L; Majidzadeh-A K
Mol Ther Nucleic Acids; 2017 Jun; 7():164-180. PubMed ID: 28624192
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy based on interleukin-12 loaded chitosan nanoparticles in a mouse model of fibrosarcoma.
Soofiyani SR; Hallaj-Nezhadi S; Lotfipour F; Hosseini AM; Baradaran B
Iran J Basic Med Sci; 2016 Nov; 19(11):1238-1244. PubMed ID: 27917281
[TBL] [Abstract][Full Text] [Related]
15. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.
Aravind A; Yoshida Y; Maekawa T; Kumar DS
Drug Deliv Transl Res; 2012 Dec; 2(6):418-36. PubMed ID: 25787323
[TBL] [Abstract][Full Text] [Related]
17. Current status of gene therapy for breast cancer: progress and challenges.
McCrudden CM; McCarthy HO
Appl Clin Genet; 2014; 7():209-20. PubMed ID: 25419154
[TBL] [Abstract][Full Text] [Related]
18. Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.
Desai PR; Marepally S; Patel AR; Voshavar C; Chaudhuri A; Singh M
J Control Release; 2013 Aug; 170(1):51-63. PubMed ID: 23643662
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene.
Nam K; Nam HY; Kim PH; Kim SW
Biomaterials; 2012 Nov; 33(32):8122-30. PubMed ID: 22871423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
